Z Saif1, N A Hodyl1, M J Stark1, P J Fuller2, T Cole3, N Lu4, V L Clifton5. 1. Robinson Research Institute, School of Paediatrics and Reproductive Health, University of Adelaide, Adelaide, SA, Australia. 2. Endocrinology, Monash Health, MIMR-PHI Institute, Monash University, Melbourne, VIC, Australia. 3. Department of Biochemistry & Molecular Biology, Faculty of Medicine, Monash University, Clayton, VIC, Australia. 4. Division of Allergy-Immunology, Department of Medicine, Northwestern University, Chicago, IL, USA. 5. Robinson Research Institute, School of Paediatrics and Reproductive Health, University of Adelaide, Adelaide, SA, Australia. Electronic address: Vicki.clifton@adelaide.edu.au.
Abstract
INTRODUCTION: Administration of betamethasone to women at risk of preterm delivery is known to be associated with reduced fetal growth via alterations in placental function and possibly direct effects on the fetus. The placental glucocorticoid receptor (GR) is central to this response and recent evidence suggests there are numerous isoforms for GR in term placentae. In this study we have questioned whether GR isoform expression varies in preterm placentae in relation to betamethasone exposure, fetal sex and birthweight. METHODS: Preterm (24-36 completed weeks of gestation, n = 55) and term placentae (>37 completed weeks of gestation, n = 56) were collected at delivery. Placental GR expression was examined using Western Blot and analysed in relation to gestational age at delivery, fetal sex, birthweight and betamethasone exposure. Data was analysed using non-parametric tests. RESULTS: Eight known isoforms of the GR were detected in the preterm placenta and include GRα (94 kDa), GRβ (91 kDa), GRα C (81 kDa) GR P (74 kDa) GR A (65 kDa), GRα D1-3 (50-55 kDa). Expression varied between preterm and term placentae with a greater expression of GRα C in preterm placentae relative to term placentae. The only sex differences in preterm placentae was that GRα D2 expression was higher in males than females. There were no alterations in preterm placental GR expression in association with betamethasone exposure. DISCUSSION: GRα C is the isoform involved in glucocorticoid induced apoptosis and suggests that its predominance in preterm placentae may contribute to the pathophysiology of preterm birth.
INTRODUCTION: Administration of betamethasone to women at risk of preterm delivery is known to be associated with reduced fetal growth via alterations in placental function and possibly direct effects on the fetus. The placental glucocorticoid receptor (GR) is central to this response and recent evidence suggests there are numerous isoforms for GR in term placentae. In this study we have questioned whether GR isoform expression varies in preterm placentae in relation to betamethasone exposure, fetal sex and birthweight. METHODS: Preterm (24-36 completed weeks of gestation, n = 55) and term placentae (>37 completed weeks of gestation, n = 56) were collected at delivery. Placental GR expression was examined using Western Blot and analysed in relation to gestational age at delivery, fetal sex, birthweight and betamethasone exposure. Data was analysed using non-parametric tests. RESULTS: Eight known isoforms of the GR were detected in the preterm placenta and include GRα (94 kDa), GRβ (91 kDa), GRα C (81 kDa) GR P (74 kDa) GR A (65 kDa), GRα D1-3 (50-55 kDa). Expression varied between preterm and term placentae with a greater expression of GRα C in preterm placentae relative to term placentae. The only sex differences in preterm placentae was that GRα D2 expression was higher in males than females. There were no alterations in preterm placental GR expression in association with betamethasone exposure. DISCUSSION: GRα C is the isoform involved in glucocorticoid induced apoptosis and suggests that its predominance in preterm placentae may contribute to the pathophysiology of preterm birth.
Authors: M Tare; S L Miller; E M Wallace; A E Sutherland; T Yawno; H A Coleman; G Jenkin; H C Parkington Journal: BJOG Date: 2012-07 Impact factor: 6.531
Authors: Alice M Graham; Jerod M Rasmussen; Sonja Entringer; Elizabeth Ben Ward; Marc D Rudolph; John H Gilmore; Martin Styner; Pathik D Wadhwa; Damien A Fair; Claudia Buss Journal: Biol Psychiatry Date: 2018-07-07 Impact factor: 13.382
Authors: Kenneth Ayuurebobi Ae-Ngibise; Blair J Wylie; Ellen Boamah-Kaali; Darby W Jack; Felix Boakye Oppong; Steven N Chillrud; Stephaney Gyaase; Seyram Kaali; Oscar Agyei; Patrick L Kinney; Mohammed Mujtaba; Rosalind J Wright; Kwaku Poku Asante; Alison G Lee Journal: BMC Pregnancy Childbirth Date: 2019-10-29 Impact factor: 3.007
Authors: S L Young; Z Saif; A S Meakin; E S McMaster; N Hayes; L A Gallo; N Reid; K M Moritz; V L Clifton Journal: Reprod Sci Date: 2021-01-06 Impact factor: 3.060
Authors: Ashley S Meakin; James S M Cuffe; Jack R T Darby; Janna L Morrison; Vicki L Clifton Journal: Int J Mol Sci Date: 2021-06-15 Impact factor: 5.923
Authors: G Garcia-Ruíz; P Flores-Espinosa; E Preciado-Martínez; L Bermejo-Martínez; A Espejel-Nuñez; G Estrada-Gutierrez; R Maida-Claros; A Flores-Pliego; Veronica Zaga-Clavellina Journal: Reprod Biol Endocrinol Date: 2015-10-07 Impact factor: 5.211